2022-02-14T13:09:08-06:00 2021-03-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2020-04-01 131949477 NEW YORK BLOOD CENTER INC NEWY 2125703100 310 EAST 67TH STREET NEW YORK NY 10065 JOSEPH S MOHR CFO 2125703100 2022-02-15 1 JOSEPH MOHR XXX-XX-XXXX LAURA J KENNEY P00202198 6177170831 2022-02-07 0 AAL1 IAL1 2020 2022-09-23 18:48:47Z DR CHRISTOPHER HILLYER 310 EAST 67TH STREET NEW YORK NY 10065 1127156048 0 X NYBLOODCENTER.ORG X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION.SPECIFICALLY, NYBC EXISTS:- TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS.- TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH- TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT- TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS 19 18 2738 730 160448 0 13809977 24165905 437376620 528661629 31435059 881408 902157 1006876 483523813 554715818 94681 46761 0 0 178275431 190883146 0 0 123700 304464849 316165078 482834961 507094985 688852 47620833 515795702 653903495 91488744 98848143 424306958 555055352 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C. 0 0 297444194 46761 380488695 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS,TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TOHOSPITALS IN 17 STATES FOR TRANSFUSIONS TO PATIENTS. 143152056 148172934 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES(INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM;AND (3) HEMOPHILIA SERVICES CONSORTIUM.NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING ANDSTORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITSFOR TREATMENT OR FOR RESEARCH PURPOSES. 21977162 0 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES AWIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD ANDBLOOD RELATED DISEASES. 462573412 1 1 0 1 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 329 0 1 2738 1 1 1 0 0 0 0 0 0 0 0 0 1 0 X 19 18 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL IN MA MD MI MN NC NJ NY OK PA RI TN VA X JOSEPH S MOHR 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 CHRISTOPHER HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 1975744 0 52735 AVERY AUGUST TRUSTEE 1.00 X 0 0 0 JUNG CHOI TRUSTEE 1.00 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.00 X 0 0 0 PHILIP J FALIVENE TRUSTEE 1.00 X 0 0 0 JOHN FERRETTI TRUSTEE 1.00 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.00 X 0 0 0 OWEN GARRICK TRUSTEE 1.00 X 0 0 0 MARC KRAMER CHAIR, BOARD OF TRUSTEES 1.00 X 0 0 0 PETER LOPEZ TRUSTEE 1.00 X 0 0 0 AARON R MARCU TRUSTEE 1.00 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.00 X 0 0 0 CHARLES REPPUCCI TRUSTEE 1.00 X 0 0 0 JOHN L ROSENTHAL TRUSTEE 1.00 X 0 0 0 JAIME SHAMONKI TRUSTEE 1.00 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.00 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 1.00 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.00 X 0 0 0 STEPHEN D WURTZLER TRUSTEE 1.00 X 0 0 0 DAVID TENDLER TRUSTEE (THROUGH 10/2020) 1.00 X 0 0 0 FAYE WATTLETON TRUSTEE (THROUGH 10/2020) 1.00 X 0 0 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 50.00 X 826349 0 40499 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 50.00 X 480880 0 52141 ROBERT PURVIS CHIEF OF STAFF 50.00 X 467577 0 52362 BETSY JETT SVP - CHIEF QUAL & REGULATORY OFCR 50.00 X 449562 0 31106 BRUCE SACHAIS VP, CHIEF MEDICAL OFFICER 50.00 X 362769 0 52032 JOON MOON INTERIM CFO (THROUGH 8/2020) 50.00 X 338118 0 59055 BETH SHAZ SVP - CMO (THROUGH 6/2020) 50.00 X 336725 0 20488 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETARY 50.00 X 268563 0 50681 JOSEPH MOHR AS OF 92020 CHIEF FINANCIAL AND BUSINESS OFFICER 50.00 X 150163 0 20635 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 50.00 X 341755 0 39665 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 50.00 X 322056 0 47692 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION 50.00 X 309664 0 43399 DAVID GRAHAM VP-NYBC DIVISIONS 50.00 X 300665 0 49985 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 50.00 X 233558 0 29588 MOHANDAS NARLA VP - LFRKI 50.00 X 369573 0 41899 CONNIE WESTHOFF EXECUTIVE SCIENTIFIC DIRECTOR- IMMUNOHEMATOLOGY 50.00 X 348428 0 40301 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS 50.00 X 287689 0 61167 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 50.00 X 281057 0 40740 KARINA YAZDANBAKHSH VP, DIRECTOR, RESEARCH DEVELOPMENT LFKRI 50.00 X 226687 0 23470 8677582 0 849640 217 0 1 0 INCEPT 4150 BELDEN VILLAGE STREET CANTON OH 44718 BLOOD DONOR MARKETING 2916134 ATOS IT SOLUTIONS AND SERVICE PO BOX 710878 COLUMBUS OH 43271 IT SERVICES 2409715 CROSSROADS COURIER 2008 ALTOM CT SAINT LOUIS MO 63146 MESSENGER 2014525 DOUGHERTY CLIFFORD & WADSWORTH 895 MARCONI AVENUE RONKONKOMA NY 11779 ADVERTISING FOR BLOOD DONORS 1673600 CENTURY PROTECTIVE SERVICES 150 GRAND STREET WHITE PLAINS NY 10601 SECURITY 1393194 79 20735325 3430580 44349 24165905 BLOOD SERVICES 621500 380488695 380488695 MEDICAL PROGRAMS 621500 148172934 148172934 528661629 543995 160448 383547 1006876 0 1006876 1006876 1006876 572126000 651643 572187570 252660 -61570 398983 337413 337413 554715818 528661629 160448 1727836 25000 25000 21761 21761 7026835 843220 6183615 137667826 127637299 9947908 82619 6477346 4222790 2248987 5569 23877330 22873486 988273 15571 15833809 13756052 2072218 5539 58139 58139 1926425 80474 1845951 336383 336383 584773 584773 1518572 1518572 4803430 1574414 3229016 3733948 3573472 156472 4004 847817 784284 63533 2706135 2706135 7024852 6345940 678912 740172 740172 958307 958307 15023697 10697394 4326000 303 3329000 2540000 789000 SUPPLIES 203618095 202472838 1145257 TESTING FEES 33456659 33456659 R&M & EQUIPMENT 11126000 9583000 1543000 MGMT FEE-HEMOPHILIA CON 10419708 10419708 13952966 9382369 4560502 10095 507094985 462573412 44397873 123700 36005288 57051493 29945985 26566757 0 0 64019134 79719744 0 0 0 0 0 0 37068955 29632026 5048386 6027493 299310049 202514608 99180930 96795441 1444955 1136798 241137713 337210440 0 0 19190 0 1925166 19763303 515795702 653903495 62552947 75427912 0 0 8716419 3171603 7203548 6978114 0 0 0 0 8998154 8983672 0 0 4017676 4286842 91488744 98848143 X 423775410 554850124 531548 205228 424306958 555055352 515795702 653903495 47620833 83127561 0 X 0 1 X 1 1 1 X 12829969 12883405 13590606 13809977 24165905 77279862 319980728 321238027 346596532 437376620 528661629 1953853536 332810697 334121432 360187138 451186597 552827534 2031133398 777863 138183 104344 120000 44804 1185194 0 777863 138183 104344 120000 44804 1185194 2029948204 8457352 8505075 11907059 6483089 1550871 36903446 8457352 8505075 11907059 6483089 1550871 36903446 341268049 342626507 372094197 457669686 554378405 2068036844 0.98160 0.97530 0.01780 0.02390 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 584773 584773 506510212 507094985 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 178101 197900 511873 584773 1472647 250000 250000 250000 250000 1000000 1500000 17121175 17121175 118601234 69900857 48700377 139495982 109989976 29506006 24091658 22623775 1467883 96795441 INVESTMENT ACCOUNT 1818479 F INVESTMENT FUNDS 335391961 F 337210440 FMV OF INTEREST RATE SWAP 1007298 OTHER CURRENT LIABILITIES 2019000 OTHER LONG TERM LIABILITIES 1260544 4286842 X 635498956 83127561 138546 83266107 552232849 1518572 964397 2482969 554715818 504750562 138546 138546 504612016 1518572 964397 2482969 507094985 PART X, LINE 2: THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NONPROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NONPROFIT CORPORATION, THE ORGANIZATION IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER IRC SECTION 511. THERE WAS NO UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED MARCH 31, 2021 AND 2020. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTEREST EXPENSE INCLUDED IN FINANCIAL STATEMENT REVENUE 958,307. BAD DEBT EXPENSE INCLUDED IN FINANCIAL STATEMENT REVENUE 6,090. PART XII, LINE 4B - OTHER ADJUSTMENTS: INTEREST EXPENSE INCLUDED IN FINANCIAL STATEMENT REVENUE 958,307. BAD DEBT EXPENSE INCLUDED IN FINANCIAL STATEMENT REVENUE 6,090. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 430796 CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 2376986 0 0 0 0 0 0 2807782 0 2807782 1 0 1 1 1 0 PART III ACCOUNTING METHOD: 1 AABB NBF 8101 GLENBROOK RD BETHESDA MD 20814 362384118 501(C)(3) 25000 GENERAL SUPPORT 1 0 COLLEGE SCHOLARSHIPS 88 21761 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATION LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III COLLEGE SCHOLARSHIPS ARE AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X 0 1 0 0 0 0 0 1 0 CHRISTOPHER HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 1067932 0 850000 0 57812 0 19950 0 32785 0 2028479 0 48812 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 671293 0 131325 0 23731 0 28500 0 11999 0 866848 0 23731 0 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 430743 0 42911 0 7226 0 19950 0 32191 0 533021 0 7226 0 ROBERT PURVIS CHIEF OF STAFF 404141 0 60065 0 3371 0 19950 0 32412 0 519939 0 3371 0 BETSY JETT SVP - CHIEF QUAL & REGULATORY OFCR 404307 0 39655 0 5600 0 19950 0 11156 0 480668 0 5600 0 BRUCE SACHAIS VP, CHIEF MEDICAL OFFICER 337276 0 25493 0 0 0 19950 0 32082 0 414801 0 0 0 MOHANDAS NARLA VP - LFRKI 369573 0 0 0 0 0 19950 0 21949 0 411472 0 0 0 JOON MOON INTERIM CFO (THROUGH 8/2020) 306999 0 31119 0 0 0 28500 0 30555 0 397173 0 0 0 CONNIE WESTHOFF EXECUTIVE SCIENTIFIC DIRECTOR- IMMUN 332123 0 16305 0 0 0 19950 0 20351 0 388729 0 0 0 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 298127 0 24128 0 19500 0 10498 0 29167 0 381420 0 0 0 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 300426 0 21630 0 0 0 28500 0 19192 0 369748 0 0 0 BETH SHAZ SVP - CMO (THROUGH 6/2020) 264175 0 56100 0 16450 0 19950 0 538 0 357213 0 16450 0 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPT 288034 0 21630 0 0 0 19950 0 23449 0 353063 0 0 0 DAVID GRAHAM VP-NYBC DIVISIONS 279665 0 21000 0 0 0 19950 0 30035 0 350650 0 0 0 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECT 273835 0 13854 0 0 0 28308 0 32859 0 348856 0 0 0 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 267583 0 13474 0 0 0 11552 0 29188 0 321797 0 0 0 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETAR 251343 0 17220 0 0 0 18269 0 32412 0 319244 0 0 0 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 216563 0 16995 0 0 0 16206 0 13382 0 263146 0 0 0 KARINA YAZDANBAKHSH VP, DIRECTOR, RESEARCH DEVELOPMENT L 226687 0 0 0 0 0 22632 0 838 0 250157 0 0 0 JOSEPH MOHR AS OF 92020 CHIEF FINANCIAL AND BUSINESS OFFICER 130663 0 0 0 19500 0 10662 0 9973 0 170798 0 0 0 PART I, LINE 4B THE INDIVIDUALS LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. PAYMENTS WERE VESTED AND RECEIVED IN 2020 AND INCLUDABLE IN INCOME. - ELIZABETH MCQUAIL - $23,731 - CHRISTOPHER HILLYER - $48,812 - ROBERT PURVIS - $3,371 - JORDANA SCHWARTZ - $7,226 - BETH SHAZ - $16,450 - BETSY JETT - $5,600 PART I, LINE 7 UPON THE ORGANIZATION ACHIEVING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 5% OR 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. A RHODE ISLAND HEALTH AND EDUCATIONAL BUILDING CORPORATION 521300173 2012-06-29 9000000 CONSTRUCTION OF AN ADDITION & RENOVATION OF FACILITIES 0 0 0 A 9000000 98450 8497647 403903 2014 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 0 1 0 0 0 0 0 1 A 1 SCHEDULE K, PART I, BOND ISSUES PROCEEDS FROM THE BOND WERE TO BE USED TO FINANCE THE ACQUISITION, CONSTRUCTION, EQUIPPING AND FURNISHING OF A 20,000 SQUARE FOOT ADDITION ADJACENT TO THE MAIN FACILITY. THE ADDITION HOUSES THE ORGANIZATION'S OPERATIONAL REGULATORY FUNCTIONS, INCLUDING LABORATORIES AND DISTRIBUTION FUNCTIONS. IN ADDITION, RENOVATIONS AND IMPROVEMENTS WERE MADE TO THE ORGANIZATION'S MAIN FACILITY LOCATED AT 405 PROMENADE ST, PROVIDENCE, RI. SCHEDULE K, PART II , LINE 11 THE PROCEEDS FROM THE BOND ISSUE WERE PROVIDED IN THE FORM OF A DRAW DOWN FACILITY FROM WHICH PROCEEDS COULD BE DRAWN DOWN UNTIL MARCH 29, 2014. ALL AMOUNTS DRAWN WERE USED FOR CAPITAL EXPENDITURES AND BOND ISSUANCE COSTS IN THE AMOUNTS AS DESCRIBED ABOVE. ON MARCH 29, 2014, THE DRAW DOWN FACILITY CONVERTED TO A LOAN PAYABLE REQUIRING PRINCIPAL AND INTEREST PAYMENTS. AT THE CONVERSION DATE, THE TOTAL OUTSTANDING BORROWINGS AMOUNTED TO $8,596,097. A PREPAYMENT WAS MADE ON THE BOND FOR THE BALANCE OF THE BOND ISSUE, $403,903. X 7 44349 COST 0 1 0 FORM 990 SCHEDULE M PART I LINE 19 THE NUMBER OF NON-CASH CONTRIBUTIONS RECEIVED IS REPORTED IN COLUMN (B). FORM 990, PART VI, SECTION B, LINE 11B FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM WITH INFORMATION PROVIDED BY MANAGEMENT, AND REVIEWED AND APPROVED BY THE AUDIT COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW AND APPROVAL AT ITS ANNUAL MEETING, PRIOR TO BEING FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C AT THE BEGINNING OF EACH NEW FISCAL YEAR, AND ON AN AS-NEEDED BASIS, THE ORGANIZATION REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS AND, IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE ORGANIZATION MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS, THE ORGANIZATION USES ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND ANNUAL APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE UPON REQUEST, AND ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE BOTH UPON REQUEST AND ON ITS WEBSITE. FORM 990, PART VI, SECTION A, LINE 1A: THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD.